Pharma Marketing Network Home

John Mack

Pharma Marketing Blog represents the opinions of
John Mack
Publisher of
Pharma Marketing News.



We accept advertising relevant to the interests of our members.
For more information, see:

Media Kit





Operated by:
VirSci Corporation
PO Box 760
Newtown, PA 18940
215-504-4164
215-504-5739 (FAX)
E-mail: infovirsci@virsci.com
Pharma Marketing Blog


My Humble Opinion
Pharma Marketing Blog
Other People's Opinion
Pharma Marketing Talk
A "Must Read" Blog for Insiders. -- Wall Street Journal A bi-weekly podcast. Listen and call-in live online or download to your iPod!

| Also see Pharma Marketing News OpEd Pieces |

Yummi! It's Zimulti!

Posted: May 3, 2007

According to the Acomplia Report, "It's now official. If diet drug Acomplia (rimonabant) is ultimately approved for sale in the United States, the prescription diet pill will go on the U.S. market not as Acomplia but as Zimulti."

While this is bad news for the Acomplia Report, which will have to change it's name, I guess, and is perhaps a mild setback for Sanofi-Aventis, which plans to market the diabetes drug in the US, it is definitely good news for bloggers.

I think it's a great name for an Italian dessert, which makes the name much more ironic because sugary desserts may be the last thing a diabetes/obesity drug name should conjure up in the minds of patients.

For more, plus a graphic illustrating the New Zimulti Dessert, see today's post to Pharma Marketing Blog.

For more posts in related topic areas, see:

If you wish to receive notice by email whenever a post is made to Pharma Marketing Blog, please subscribe.

Enter your Email Address

| Return to Pharma Marketing Blog Topics |

Special Supplement
Increase Physician Access and Detailing Effectiveness

SFE Supplement Cover Everyone knows that pharma sales reps are less effective than they used to be. Although the pharmaceutical sales force has doubled between 1995 and 2000, the number of audited calls has only increased by 10%.

Through articles and real-world case studies this Special Supplement to Pharma Marketing News presents the collective wisdom of many marketing experts who offer solutions to the problem of decreasing sales rep effectiveness and decreasing return on the physician marketing dollar.

TABLE OF CONTENTS

Order and pay for this Special Supplement now using your credit card.

ONLY $29.95
PDF file delivered to you by email (usually within minutes of placing your order).

If you wish to be invoiced and/or pay by check, please use:
Printable Order Form


Pharma Marketing News | Subscribe | Discussion Forums | Roundtable | Podcasts | Blog
Daily News Briefs | Surveys | Resources/Links | Glossary | Case Studies | Reports
Pharma Marketing Vendor Directory | Conference Calendar | Pharma Jobs
Advertising Information | FAQs | About Us | Privacy Policy

© 2007. VirSci Corporation. All rights reserved.